HER2 Support Group Forums - View Single Post - Interesting article/clinical trial/preventing bone mets stage I-III

CherylS · 03-23-2006, 05:04 PM

I talked to my onc. pharmacist today and he had done some checking for me. He said that clodronate was submitted for approval to the FDA in Jan. of 2005,
nothing further. Go figure. The other's, Aredia and Zometra are intraveneous drugs and insurance won't cover them unless bone mets have already occurred. Clodronate is an oral medication. Again, go figure. He said that the FDA requires two conclusive clinical trials. Looks like we've got those, so what's the problem? Almost 1 1/2 years after submittal for approval we have nothing.

03-23-2006, 05:04 PM	#10
CherylS Senior Member Join Date: Oct 2005 Location: Minneapolis, MN Posts: 189	I talked to my onc. pharmacist today and he had done some checking for me. He said that clodronate was submitted for approval to the FDA in Jan. of 2005, nothing further. Go figure. The other's, Aredia and Zometra are intraveneous drugs and insurance won't cover them unless bone mets have already occurred. Clodronate is an oral medication. Again, go figure. He said that the FDA requires two conclusive clinical trials. Looks like we've got those, so what's the problem? Almost 1 1/2 years after submittal for approval we have nothing. __________________ Cheryl